Vitamin D Signaling through Induction of Paneth Cell Defensins Maintains Gut Microbiota and Improves Metabolic Disorders and Hepatic Steatosis in Animal Models
暂无分享,去创建一个
Pengfei Wu | S. Pandol | A. Lugea | H. Tsukamoto | Qun Sun | Yuanping Han | Z. Duan | Airu Zhu | Richard Hu | S. Zheng | Mei Luo | Danmei Su | Zhixiong Xiao | Y. Lai | Y. Nie | Guihui Wu | Zhenqui Liu | Li Zhang | Zishuo Chen | Linbin Cai
[1] James E. Nelson,et al. Vitamin D Deficiency Is Associated With Increased Risk of Non-alcoholic Steatohepatitis in Adults With Non-alcoholic Fatty Liver Disease: Possible Role for MAPK and NF-κB? , 2016, The American Journal of Gastroenterology.
[2] T. Buchanan,et al. θ-Defensin RTD-1 improves insulin action and normalizes plasma glucose and FFA levels in diet-induced obese rats. , 2015, American journal of physiology. Endocrinology and metabolism.
[3] Yuanping Han,et al. Spontaneous liver fibrosis induced by long term dietary vitamin D deficiency in adult mice is related to chronic inflammation and enhanced apoptosis. , 2015, Canadian journal of physiology and pharmacology.
[4] E. Jacobs,et al. Concentrations of the vitamin D metabolite 1,25(OH)2D and odds of metabolic syndrome and its components. , 2015, Metabolism: clinical and experimental.
[5] S. Pandol,et al. Vitamin D deficiency promotes nonalcoholic steatohepatitis through impaired enterohepatic circulation in animal model. , 2014, American journal of physiology. Gastrointestinal and liver physiology.
[6] B. Hamdi,et al. Vitamin D reduces the differentiation and expansion of Th17 cells in young asthmatic children. , 2014, Immunobiology.
[7] C. Mathieu,et al. Dietary Supplementation With High Doses of Regular Vitamin D3 Safely Reduces Diabetes Incidence in NOD Mice When Given Early and Long Term , 2014, Diabetes.
[8] C. Rogers,et al. Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis. , 2013, The Journal of nutrition.
[9] Lucie Geurts,et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity , 2013, Proceedings of the National Academy of Sciences.
[10] R. Evans,et al. A Vitamin D Receptor/SMAD Genomic Circuit Gates Hepatic Fibrotic Response , 2013, Cell.
[11] D. Bending,et al. Th17-cell plasticity in Helicobacter hepaticus–induced intestinal inflammation , 2013, Mucosal Immunology.
[12] K. Brown,et al. Diet-Induced Dysbiosis of the Intestinal Microbiota and the Effects on Immunity and Disease , 2012, Nutrients.
[13] J. Nicholson,et al. Host-Gut Microbiota Metabolic Interactions , 2012, Science.
[14] P. Holt,et al. A high-fat diet is associated with endotoxemia that originates from the gut. , 2012, Gastroenterology.
[15] James E. Nelson,et al. Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and toll‐like receptor activation , 2012, Hepatology.
[16] Chao-Long Chen,et al. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. , 2011, Journal of hepatology.
[17] M. Holick. Vitamin D , 2011, Journal of Investigative Medicine.
[18] S. Morini,et al. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes , 2011, BMC medicine.
[19] A. Brett. Evaluation, Treatment, and Prevention of Vitamin D Deficiency , 2011 .
[20] C. Gordon,et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.
[21] S. Ichikawa,et al. Hepatic Stellate Cells Function as Regulatory Bystanders , 2011, The Journal of Immunology.
[22] C. Dejong,et al. Reduced Paneth cell antimicrobial protein levels correlate with activation of the unfolded protein response in the gut of obese individuals , 2011, The Journal of pathology.
[23] C. Sempos,et al. Vitamin D status: United States, 2001-2006. , 2011, NCHS data brief.
[24] K. Hirata,et al. Oral Administration of an Active Form of Vitamin D3 (Calcitriol) Decreases Atherosclerosis in Mice by Inducing Regulatory T Cells and Immature Dendritic Cells With Tolerogenic Functions , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[25] Chen Dong,et al. Vitamin D Suppresses Th17 Cytokine Production by Inducing C/EBP Homologous Protein (CHOP) Expression* , 2010, The Journal of Biological Chemistry.
[26] S. Bryssine,et al. [The prevalence of metabolic syndrome]. , 2010, Soins. Psychiatrie.
[27] S. Fukuda,et al. Serological analysis of Helicobacter hepaticus infection in patients with biliary and pancreatic diseases , 2010, Journal of gastroenterology and hepatology.
[28] S. Sørensen,et al. Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults , 2010, PloS one.
[29] J. Adams,et al. Update in vitamin D. , 2010, The Journal of clinical endocrinology and metabolism.
[30] G. Weinstock,et al. Enteric defensins are essential regulators of intestinal microbial ecology , 2009, Nature Immunology.
[31] K. Chayama,et al. Detection of Helicobacter hepaticus in Human Bile Samples of Patients with Biliary Disease , 2009, Helicobacter.
[32] A. Ouellette,et al. Alpha-defensins in enteric innate immunity: functional Paneth cell alpha-defensins in mouse colonic lumen. , 2009, The Journal of biological chemistry.
[33] O. Franco,et al. Plasma 25-Hydroxyvitamin D Concentration and Metabolic Syndrome Among Middle-Aged and Elderly Chinese Individuals , 2009, Diabetes Care.
[34] W. Cefalu. Inflammation, Insulin Resistance, and Type 2 Diabetes: Back to the Future? , 2009, Diabetes.
[35] H. Escobar-Morreale,et al. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. , 2007, Clinical nutrition.
[36] J. Ferrières,et al. Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.
[37] F. Dewhirst,et al. Enterohepatic Helicobacter Species Are Prevalent in Mice from Commercial and Academic Institutions in Asia, Europe, and North America , 2007, Journal of Clinical Microbiology.
[38] S Kumar,et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. , 2007, American journal of physiology. Endocrinology and metabolism.
[39] A. Sher,et al. IL-23 plays a key role in Helicobacter hepaticus–induced T cell–dependent colitis , 2006, The Journal of experimental medicine.
[40] Jeffrey I. Gordon,et al. Reciprocal Gut Microbiota Transplants from Zebrafish and Mice to Germ-free Recipients Reveal Host Habitat Selection , 2006, Cell.
[41] Yan Zhu,et al. Vitamin D receptor is required to control gastrointestinal immunity in IL‐10 knockout mice , 2006, Immunology.
[42] C. Kahn,et al. From mice to men: insights into the insulin resistance syndromes. , 2006, Annual review of physiology.
[43] E. Ford,et al. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. , 2005, Diabetes care.
[44] C. Bevins,et al. Mechanisms of Disease: defensins in gastrointestinal diseases , 2005, Nature Clinical Practice Gastroenterology &Hepatology.
[45] F. Bäckhed,et al. Obesity alters gut microbial ecology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[46] X. Tian,et al. Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma , 2004, Journal of Clinical Pathology.
[47] Ting Wang,et al. The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[48] H. Kaneto,et al. Modulation of the JNK Pathway in Liver Affects Insulin Resistance Status* , 2004, Journal of Biological Chemistry.
[49] W. D. de Vos,et al. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. , 2004, International journal of systematic and evolutionary microbiology.
[50] F. Mégraud,et al. Natural History of Helicobacter hepaticus Infection in Conventional A/J Mice, with Special Reference to Liver Involvement , 2003, Infection and Immunity.
[51] Z. Bloomgarden,et al. Inflammation and insulin resistance. , 2003, Diabetes care.
[52] Michael Karin,et al. A central role for JNK in obesity and insulin resistance , 2002, Nature.
[53] D. Breuillé,et al. High-fat diet. , 2000 .
[54] William C. Parks,et al. Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria , 2000, Nature Immunology.
[55] R. Baron,et al. Rescue of the Skeletal Phenotype of Vitamin D Receptor-Ablated Mice in the Setting of Normal Mineral Ion Homeostasis: Formal Histomorphometric and Biomechanical Analyses1. , 1999, Endocrinology.
[56] L. Matrisian,et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. , 1999, Science.
[57] R. Baron,et al. Printed in U.S.A. Copyright © 1999 by The Endocrine Society Rescue of the Skeletal Phenotype of Vitamin D Receptor- Ablated Mice in the Setting of Normal Mineral Ion , 2022 .
[58] J M Ward,et al. Helicobacter hepaticus Triggers Colitis in Specific-Pathogen-Free Interleukin-10 (IL-10)-Deficient Mice through an IL-12- and Gamma Interferon-Dependent Mechanism , 1998, Infection and Immunity.
[59] C. Day,et al. Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.
[60] A. Ouellette,et al. Positional specificity of defensin gene expression reveals Paneth cell heterogeneity in mouse small intestine. , 1996, The American journal of physiology.
[61] Z. Shen,et al. Identification of widespread Helicobacter hepaticus infection in feces in commercial mouse colonies by culture and PCR assay , 1995, Journal of clinical microbiology.
[62] M. Selsted,et al. Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms , 1994, Infection and immunity.
[63] J. Ward,et al. Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice , 1994, Journal of clinical microbiology.
[64] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[65] T. Oppé,et al. Vitamin D deficiency. , 1979, British medical journal.
[66] R. Regan,et al. DETECTION OF , 2012 .